Survival, neurocognitive function, and health-related quality of life outcomes after rituximab-methotrexate, BCNU, teniposide, and prednisolone for primary CNS lymphoma: Final results of the HOVON 105/ALLG NHL 24 study
利妥昔单抗-甲氨蝶呤、卡莫司汀、替尼泊苷和泼尼松龙治疗原发性中枢神经系统淋巴瘤后的生存率、神经认知功能和健康相关生活质量结局:HOVON 105/ALLG NHL 24 研究的最终结果
期刊:Neuro-Oncology
影响因子:13.4
doi:10.1093/neuonc/noad224
Bromberg, Jacoline E C; Issa, Samar; van der Holt, Bronno; van der Meulen, Matthijs; Dirven, Linda; Minnema, Monique C; Seute, Tatjana; Durian, Marc; Cull, Gavin; van der Poel, Marjolein W M; Stevens, Wendy B C; Zijlstra, Josee M; Brandsma, Dieta; Nijland, Marcel; Mason, Kylie D; Beeker, Aart; Abrahamse-Testroote, Martine C J; van den Bent, Martin J; de Jong, Daphne; Doorduijn, Jeanette K